Transformando el futuro de la industria farmacéutica
Email: info@amarintech.com.ar
The presence of pharmaceutical compounds in the environment is an emerging problem that the industry can no longer ignore. Eco-pharmacology — the discipline studying the effects of drugs on ecosystems — is gaining traction in global regulatory frameworks and in the sustainability agendas of pharmaceutical companies. Understanding the origins of [...]
In the pharmaceutical business, supply chain management plays a fundamental role in delivering the necessary raw materials for the production of safe pharmaceutical forms intended for patients and end consumers. It also involves the precise and timely coordination of finished products not only for the domestic market but also for [...]
The use of Quality by Design (QbD) concept to medicated plasters (patches) development gives us the certainty to obtain safety and reliable products for patients with verifiable efficacy, long before they enter their production stage. [...]
In this article, we will examine the evolution, prospects, and current challenges of the generic drug market in the United States. [...]
The pharmaceutical industry significantly impacts the environment due to the generation of hazardous waste, the use of energy and water, and the emission of greenhouse gases. [...]
With the large amount of information found on the internet, it is often difficult for us to differentiate truth from myth or lie. That is why in this article we collect some claims of transdermal patches and if they are true or false. [...]
La validación de limpieza en la manufactura de parches transdermales es un requisito GMP crítico que va más allá de la limpieza rutinaria de equipos. Es la demostración documentada y sistemática de que un procedimiento de limpieza aprobado elimina de manera consistente los residuos de principios activos (APIs) — y cualquier otro contaminante — a niveles que no comprometen la seguridad, identidad, potencia, calidad o pureza del siguiente producto fabricado en el mismo equipo.
In recent years, laboratories have been investigating new alternatives to eliminate or avoid animal testing of cosmetic and medical products. [...]
Correct adhesion of a transdermal patch throughout its entire wear period is not an aesthetic property — it is a drug delivery important condition. A patch that partially lifts off from the skin delivers less drug than labeled, with unpredictable pharmacokinetic consequences [...] [...]
Although the analytical procedure transfer of transdermal pharmaceutical products follows the same general guidelines as other dosage forms, .. [...]